FLT3 and acute myeloid leukemia: BV6 also sensitizes FLT3-ITD AML cells toward apoptosis and necroptosis, both alone and in combination with death ligands, for example, CD95L or tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) [31].